Trials / Withdrawn
WithdrawnNCT04268160
GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR
Glutathione Peroxidase Activity in Subjects With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this project is to investigate the association of glutathione peroxidase (GPx) and severe aortic stenosis (AS), as well as the impact of transcatheter aortic valve replacement (TAVR) on GPx activity post-procedure. The burden of oxidative stress will be determined by the measurement of GPx, superoxide dismutase (SOD) and lipoprotein A (Lp(a)). We hypothesize GPx activity is reduced in participants with severe AS vs control groups and GPx activity is to increase after TAVR is performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood draw to measure GPx activity | Routine blood draw to measure levels of blood markers. |
| DIAGNOSTIC_TEST | Blood draw to measure SOD activity | Routine blood draw to measure levels of blood markers. |
| DIAGNOSTIC_TEST | Blood draw to measure Lp(a) levels | Routine blood draw to measure levels of blood markers. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
- First posted
- 2020-02-13
- Last updated
- 2021-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04268160. Inclusion in this directory is not an endorsement.